<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02712645</url>
  </required_header>
  <id_info>
    <org_study_id>LUM-BC-1.0</org_study_id>
    <nct_id>NCT02712645</nct_id>
  </id_info>
  <brief_title>A Multicenter Breast Cancer Biospecimen Registry</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Luminist, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Luminist, Inc.</source>
  <brief_summary>
    <textblock>
      This study is being performed to collect blood for the development of noninvasive tests that
      can screen for or diagnose cancer. Blood samples will be collected from women who are
      scheduled to have breast biopsies.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2016</start_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Number of patients with untreated newly diagnosed breast cancer.</measure>
    <time_frame>1 Year</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">700</enrollment>
  <condition>Breast Cancer</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Women scheduled for a breast biopsy.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Females of all racial and ethnic groups who are 40 years or older.

          2. Women must:

               1. have suspected neoplasm of the breast (BIRADS 4 or 5) based on the results of any
                  breast screening or diagnostic imaging, such as mammogram, and

               2. be selected or scheduled for a breast biopsy which has not yet been conducted at
                  the time of enrollment.

        Exclusion Criteria:

          1. Inability to sign informed consent.

          2. More than one radiological finding.

          3. Any current or prior cancer (with the exception of non-melanoma skin cancer or a
             suspected breast malignancy targeted for biopsy).

          4. Any known or suspected acute illness or condition - including acute infections - at
             the time of enrollment or within the previous 30 days.

          5. Any surgery, hospitalization, or institutionalization (such as in a nursing home)
             during the previous 3 months.

          6. Received any experimental therapeutic treatment during the previous 3 months.

          7. Received any blood product transfusion within the previous 3 months.

          8. Use of illegal drugs during the previous 3 months.

          9. Pregnant or nursing at the time of enrollment or in the preceding 12 months.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Storm Stillman</last_name>
    <email>clinical@luminist.io</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Will Olsen</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <address>
        <city>Redding</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 15, 2016</study_first_submitted>
  <study_first_submitted_qc>March 15, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 18, 2016</study_first_posted>
  <last_update_submitted>April 4, 2016</last_update_submitted>
  <last_update_submitted_qc>April 4, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 6, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

